{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T06:45:03Z","timestamp":1786430703525,"version":"build-2736575974"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Provincial Science and Technology Support Program","doi-asserted-by":"publisher","award":["2023YFS0186"],"award-info":[{"award-number":["2023YFS0186"]}],"id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Sichuan Provincial Medical Research Youth Innovation Project","award":["202407050112"],"award-info":[{"award-number":["202407050112"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-025-01790-0","type":"journal-article","created":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T06:00:05Z","timestamp":1751954405000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["CCL22 as a diagnostic and prognostic biomarker for pediatric-onset systemic lupus erythematosus"],"prefix":"10.1007","volume":"25","author":[{"given":"Xiao-lin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-xi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-ke","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-mei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,8]]},"reference":[{"key":"1790_CR1","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1136\/bmj.39358.519491.AD","volume":"335","author":"LH Mackillop","year":"2007","unstructured":"Mackillop LH, Germain SJ, Nelson-Piercy C. Systemic lupus erythematosus. BMJ. 2007;335:933\u20136.","journal-title":"BMJ"},{"key":"1790_CR2","doi-asserted-by":"crossref","first-page":"Itc81","DOI":"10.7326\/AITC202006020","volume":"172","author":"M Kiriakidou","year":"2020","unstructured":"Kiriakidou M, Ching CL. Systemic lupus erythematosus. Ann Intern Med. 2020;172:Itc81\u201396.","journal-title":"Ann Intern Med"},{"key":"1790_CR3","volume":"209","author":"EMD Smith","year":"2019","unstructured":"Smith EMD, Lythgoe H, Midgley A, Beresford MW, Hedrich CM. Juvenile-onset systemic lupus erythematosus: update on clinical presentation, pathophysiology and treatment options. Clin Immunol (Orlando, Fla). 2019;209: 108274.","journal-title":"Clin Immunol (Orlando, Fla)"},{"key":"1790_CR4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11926-021-00985-0","volume":"23","author":"A Charras","year":"2021","unstructured":"Charras A, Smith E, Hedrich CM. Systemic lupus erythematosus in children and young people. Curr Rheumatol Rep. 2021;23:20.","journal-title":"Curr Rheumatol Rep"},{"key":"1790_CR5","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1002\/art.34472","volume":"64","author":"LT Hiraki","year":"2012","unstructured":"Hiraki LT, Feldman CH, Liu J, Alarc\u00f3n GS, Fischer MA, Winkelmayer WC, Costenbader KH. Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population. Arthritis Rheum. 2012;64:2669\u201376.","journal-title":"Arthritis Rheum"},{"key":"1790_CR6","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1177\/0961203311412096","volume":"20","author":"D Pineles","year":"2011","unstructured":"Pineles D, Valente A, Warren B, Peterson MG, Lehman TJ, Moorthy LN. Worldwide incidence and prevalence of pediatric onset systemic lupus erythematosus. Lupus. 2011;20:1187\u201392.","journal-title":"Lupus"},{"key":"1790_CR7","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S2352-4642(24)00172-X","volume":"8","author":"S Gao","year":"2024","unstructured":"Gao S, Yu Z, Ma X, Sun J, Ren A, Gao S, Gong M, Zhou X, Ma M, Song H. Childhood-onset systemic lupus erythematosus in China, 2016\u201321: a nationwide study. Lancet Child Adolesc Health. 2024;8:762\u201372.","journal-title":"Lancet Child Adolesc Health"},{"key":"1790_CR8","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nrrheum.2010.121","volume":"6","author":"S Kamphuis","year":"2010","unstructured":"Kamphuis S, Silverman ED. Prevalence and burden of pediatric-onset systemic lupus erythematosus. Nat Rev Rheumatol. 2010;6:538\u201346.","journal-title":"Nat Rev Rheumatol"},{"key":"1790_CR9","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"365","author":"GC Tsokos","year":"2011","unstructured":"Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365:2110\u201321.","journal-title":"N Engl J Med"},{"key":"1790_CR10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00296-011-2354-4","volume":"33","author":"J Zhu","year":"2013","unstructured":"Zhu J, Wu F, Huang X. Age-related differences in the clinical characteristics of systemic lupus erythematosus in children. Rheumatol Int. 2013;33:111\u20135.","journal-title":"Rheumatol Int"},{"key":"1790_CR11","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1093\/rheumatology\/kead086","volume":"62","author":"Y Hou","year":"2023","unstructured":"Hou Y, Wang L, Luo C, Tang W, Dai R, An Y, Tang X. Clinical characteristics of early-onset paediatric systemic lupus erythematosus in a single centre in China. Rheumatology (Oxford). 2023;62:3373\u201381.","journal-title":"Rheumatology (Oxford)"},{"key":"1790_CR12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.berh.2017.10.002","volume":"31","author":"N Vasquez-Canizares","year":"2017","unstructured":"Vasquez-Canizares N, Wahezi D, Putterman C. Diagnostic and prognostic tests in systemic lupus erythematosus. Best Pract Res Clin Rheumatol. 2017;31:351\u201363.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"1790_CR13","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","volume":"40","author":"MC Hochberg","year":"1997","unstructured":"Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.","journal-title":"Arthritis Rheum"},{"key":"1790_CR14","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","volume":"64","author":"M Petri","year":"2012","unstructured":"Petri M, Orbai AM, Alarc\u00f3n GS, Gordon C, Merrill JT, Fortin PR, Bruce IN, Isenberg D, Wallace DJ, Nived O, Sturfelt G, Ramsey-Goldman R, Bae SC, Hanly JG, S\u00e1nchez-Guerrero J, Clarke A, Aranow C, Manzi S, Urowitz M, Gladman D, Kalunian K, Costner M, Werth VP, Zoma A, Bernatsky S, Ruiz-Irastorza G, Khamashta MA, Jacobsen S, Buyon JP, Maddison P, Dooley MA, van Vollenhoven RF, Ginzler E, Stoll T, Peschken C, Jorizzo JL, Callen JP, Lim SS, Fessler BJ, Inanc M, Kamen DL, Rahman A, Steinsson K, Franks AG Jr, Sigler L, Hameed S, Fang H, Pham N, Brey R, Weisman MH, McGwin G Jr, Magder LS. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum. 2012;64:2677\u201386.","journal-title":"Arthritis Rheum"},{"key":"1790_CR15","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1136\/annrheumdis-2017-211898","volume":"76","author":"N Groot","year":"2017","unstructured":"Groot N, de Graeff N, Marks SD, Brogan P, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, Lahdenne P, McCann L, \u00d6zen S, Pilkington CA, Ravelli A, Royen-Kerkhof AV, Uziel Y, Vastert BJ, Wulffraat NM, Beresford MW, Kamphuis S. European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative. Ann Rheum Dis. 2017;76:1965\u201373.","journal-title":"Ann Rheum Dis"},{"key":"1790_CR16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.rdc.2021.09.003","volume":"48","author":"EM Cody","year":"2022","unstructured":"Cody EM, Brunner HI. Biomarkers in childhood-onset systemic lupus erythematosus. Rheum Dis Clin North Am. 2022;48:271\u201385.","journal-title":"Rheum Dis Clin North Am"},{"key":"1790_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/biom11070928","author":"H Yu","year":"2021","unstructured":"Yu H, Nagafuchi Y, Fujio K. Clinical and immunological biomarkers for systemic lupus erythematosus. Biomolecules. 2021. https:\/\/doi.org\/10.3390\/biom11070928.","journal-title":"Biomolecules"},{"key":"1790_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/biom13020367","author":"M Ayano","year":"2023","unstructured":"Ayano M, Horiuchi T. Complement as a biomarker for systemic lupus erythematosus. Biomolecules. 2023. https:\/\/doi.org\/10.3390\/biom13020367.","journal-title":"Biomolecules"},{"key":"1790_CR19","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jaut.2016.06.001","volume":"74","author":"R Lu","year":"2016","unstructured":"Lu R, Munroe ME, Guthridge JM, Bean KM, Fife DA, Chen H, Slight-Webb SR, Keith MP, Harley JB, James JA. Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies. J Autoimmun. 2016;74:182\u201393.","journal-title":"J Autoimmun"},{"key":"1790_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232213829","author":"MM Melamud","year":"2022","unstructured":"Melamud MM, Ermakov EA, Boiko AS, Kamaeva DA, Sizikov AE, Ivanova SA, Baulina NM, Favorova OO, Nevinsky GA, Buneva VN. Multiplex analysis of serum cytokine profiles in systemic lupus erythematosus and multiple sclerosis. Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms232213829.","journal-title":"Int J Mol Sci"},{"key":"1790_CR21","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2024.103648","volume":"23","author":"L Arnaud","year":"2024","unstructured":"Arnaud L, Chasset F, Martin T. Immunopathogenesis of systemic lupus erythematosus: an update. Autoimmun Rev. 2024;23: 103648.","journal-title":"Autoimmun Rev"},{"key":"1790_CR22","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMra052723","volume":"354","author":"IF Charo","year":"2006","unstructured":"Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med. 2006;354:610\u201321.","journal-title":"N Engl J Med"},{"key":"1790_CR23","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.immuni.2012.05.008","volume":"36","author":"A Zlotnik","year":"2012","unstructured":"Zlotnik A, Yoshie O. The chemokine superfamily revisited. Immunity. 2012;36:705\u201316.","journal-title":"Immunity"},{"key":"1790_CR24","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156770","volume":"184","author":"L Duan","year":"2024","unstructured":"Duan L, Yao Y, Kong H, Zhou Y, Cui D. Chemokines and chemokine receptors: potential therapeutic targets in systemic lupus erythematosus. Cytokine. 2024;184: 156770.","journal-title":"Cytokine"},{"key":"1790_CR25","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1182\/blood.V92.8.2668","volume":"92","author":"R Bonecchi","year":"1998","unstructured":"Bonecchi R, Sozzani S, Stine JT, Luini W, D\u2019Amico G, Allavena P, Chantry D, Mantovani A. Divergent effects of interleukin-4 and interferon-gamma on macrophage-derived chemokine production: an amplification circuit of polarized T helper 2 responses. Blood. 1998;92:2668\u201371.","journal-title":"Blood"},{"key":"1790_CR26","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1615\/CritRevImmunol.v22.i2.10","volume":"22","author":"U Yamashita","year":"2002","unstructured":"Yamashita U, Kuroda E. Regulation of macrophage-derived chemokine (MDC, CCL22) production. Crit Rev Immunol. 2002;22:105\u201314.","journal-title":"Crit Rev Immunol"},{"key":"1790_CR27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1093\/intimm\/dxu079","volume":"27","author":"O Yoshie","year":"2015","unstructured":"Yoshie O, Matsushima K. CCR4 and its ligands: from bench to bedside. Int Immunol. 2015;27:11\u201320.","journal-title":"Int Immunol"},{"key":"1790_CR28","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1084\/jem.20170277","volume":"216","author":"M Rapp","year":"2019","unstructured":"Rapp M, Wintergerst MWM, Kunz WG, Vetter VK, Knott MML, Lisowski D, Haubner S, Moder S, Thaler R, Eiber S, Meyer B, R\u00f6hrle N, Piseddu I, Grassmann S, Layritz P, K\u00fchnemuth B, Stutte S, Bourquin C, von Andrian UH, Endres S, Anz D. CCL22 controls immunity by promoting regulatory T cell communication with dendritic cells in lymph nodes. J Exp Med. 2019;216:1170\u201381.","journal-title":"J Exp Med"},{"key":"1790_CR29","first-page":"672","volume":"45","author":"ZF Xiao","year":"2024","unstructured":"Xiao ZF, Zou SS, Yi CF, Zhao Y, Wu LS, Feng YH. Expression and clinical significance of CCL17, CCL22, and CCR4 in newly diagnosed multiple myeloma. Zhonghua Xue Ye Xue Za Zhi Zhonghua Xueyexue Zazhi. 2024;45:672\u20137.","journal-title":"Zhonghua Xue Ye Xue Za Zhi Zhonghua Xueyexue Zazhi"},{"key":"1790_CR30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3002111","volume":"21","author":"S Melgrati","year":"2023","unstructured":"Melgrati S, Radice E, Ameti R, Hub E, Thelen S, Pelczar P, Jarrossay D, Rot A, Thelen M. Atlas of the anatomical localization of atypical chemokine receptors in healthy mice. PLoS Biol. 2023;21: e3002111.","journal-title":"PLoS Biol"},{"key":"1790_CR31","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0002-9440(10)63903-X","volume":"162","author":"GE Garcia","year":"2003","unstructured":"Garcia GE, Xia Y, Harrison J, Wilson CB, Johnson RJ, Bacon KB, Feng L. Mononuclear cell-infiltrate inhibition by blocking macrophage-derived chemokine results in attenuation of developing crescentic glomerulonephritis. Am J Pathol. 2003;162:1061\u201373.","journal-title":"Am J Pathol"},{"key":"1790_CR32","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/sj.gt.3301688","volume":"9","author":"J Guo","year":"2002","unstructured":"Guo J, Wang B, Zhang M, Chen T, Yu Y, Regulier E, Homann HE, Qin Z, Ju DW, Cao X. Macrophage-derived chemokine gene transfer results in tumor regression in murine lung carcinoma model through efficient induction of antitumor immunity. Gene Ther. 2002;9:793\u2013803.","journal-title":"Gene Ther"},{"key":"1790_CR33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jdermsci.2006.08.004","volume":"44","author":"S Hashimoto","year":"2006","unstructured":"Hashimoto S, Nakamura K, Oyama N, Kaneko F, Tsunemi Y, Saeki H, Tamaki K. Macrophage-derived chemokine (MDC)\/CCL22 produced by monocyte derived dendritic cells reflects the disease activity in patients with atopic dermatitis. J Dermatol Sci. 2006;44:93\u20139.","journal-title":"J Dermatol Sci"},{"key":"1790_CR34","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1158\/0008-5472.CAN-08-2360","volume":"69","author":"M Gobert","year":"2009","unstructured":"Gobert M, Treilleux I, Bendriss-Vermare N, Bachelot T, Goddard-Leon S, Arfi V, Biota C, Doffin AC, Durand I, Olive D, Perez S, Pasqual N, Faure C, Ray-Coquard I, Puisieux A, Caux C, Blay JY, M\u00e9n\u00e9trier-Caux C. Regulatory T cells recruited through CCL22\/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome. Cancer Res. 2009;69:2000\u20139.","journal-title":"Cancer Res"},{"key":"1790_CR35","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/SHK.0000000000000253","volume":"42","author":"JR Richter","year":"2014","unstructured":"Richter JR, Sutton JM, Belizaire RM, Friend LA, Schuster RM, Johannigman TA, Miller SG, Lentsch AB, Pritts TA. Macrophage-derived chemokine (CCL22) is a novel mediator of lung inflammation following hemorrhage and resuscitation. Shock. 2014;42:525\u201331.","journal-title":"Shock"},{"key":"1790_CR36","doi-asserted-by":"crossref","first-page":"599","DOI":"10.5551\/jat.27417","volume":"22","author":"S Kimura","year":"2015","unstructured":"Kimura S, Wang KY, Yamada S, Guo X, Nabeshima A, Noguchi H, Watanabe T, Harada M, Sasaguri Y. CCL22\/macrophage-derived chemokine expression in apolipoprotein E-deficient mice and effects of histamine in the setting of atherosclerosis. J Atheroscler Thromb. 2015;22:599\u2013609.","journal-title":"J Atheroscler Thromb"},{"key":"1790_CR37","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1034\/j.1399-3038.2003.00052.x","volume":"14","author":"TF Leung","year":"2003","unstructured":"Leung TF, Ma KC, Hon KL, Lam CW, Wan H, Li CY, Chan IH. Serum concentration of macrophage-derived chemokine may be a useful inflammatory marker for assessing severity of atopic dermatitis in infants and young children. Pediatr Allergy Immunol. 2003;14:296\u2013301.","journal-title":"Pediatr Allergy Immunol"},{"key":"1790_CR38","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/j.1398-9995.2005.00774.x","volume":"60","author":"K Jahnz-Rozyk","year":"2005","unstructured":"Jahnz-Rozyk K, Targowski T, Paluchowska E, Owczarek W, Kucharczyk A. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis. Allergy. 2005;60:685\u20138.","journal-title":"Allergy"},{"key":"1790_CR39","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.763292","volume":"12","author":"L Ling","year":"2021","unstructured":"Ling L, Chen Z, Lui G, Wong CK, Wong WT, Ng RWY, Tso EYK, Fung KSC, Chan V, Yeung ACM, Hui DSC, Chan PKS. Longitudinal cytokine profile in patients with mild to critical COVID-19. Front Immunol. 2021;12: 763292.","journal-title":"Front Immunol"},{"key":"1790_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713083","author":"ZR Korobova","year":"2023","unstructured":"Korobova ZR, Arsentieva NA, Totolian AA. Macrophage-derived chemokine MDC\/CCL22: an ambiguous finding in COVID-19. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241713083.","journal-title":"Int J Mol Sci"},{"key":"1790_CR41","doi-asserted-by":"crossref","unstructured":"Pacheco-Lugo L, S\u00e1enz-Garc\u00eda J, Navarro Quiroz E, Gonz\u00e1lez Torres H, Fang L, D\u00edaz-Olmos Y, Garavito de Egea G, Egea Bermejo E, Aroca Mart\u00ednez G. Plasma cytokines as potential biomarkers of kidney damage in patients with systemic lupus erythematosus. Lupus 2019; 28:34\u201343.","DOI":"10.1177\/0961203318812679"},{"key":"1790_CR42","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","volume":"71","author":"M Aringer","year":"2019","unstructured":"Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, Smolen JS, Wofsy D, Boumpas DT, Kamen DL, Jayne D, Cervera R, Costedoat-Chalumeau N, Diamond B, Gladman DD, Hahn B, Hiepe F, Jacobsen S, Khanna D, Lerstr\u00f8m K, Massarotti E, McCune J, Ruiz-Irastorza G, Sanchez-Guerrero J, Schneider M, Urowitz M, Bertsias G, Hoyer BF, Leuchten N, Tani C, Tedeschi SK, Touma Z, Schmajuk G, Anic B, Assan F, Chan TM, Clarke AE, Crow MK, Czirj\u00e1k L, Doria A, Graninger W, Halda-Kiss B, Hasni S, Izmirly PM, Jung M, Kum\u00e1novics G, Mariette X, Padjen I, Pego-Reigosa JM, Romero-Diaz J, R\u00faa-Figueroa Fern\u00e1ndez \u00cd, Seror R, Stummvoll GH, Tanaka Y, Tektonidou MG, Vasconcelos C, Vital EM, Wallace DJ, Yavuz S, Meroni PL, Fritzler MJ, Naden R, D\u00f6rner T, Johnson SR. 2019 European league against rheumatism\/american college of rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol (Hoboken, NJ). 2019;71:1400\u201312.","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"1790_CR43","first-page":"288","volume":"29","author":"DD Gladman","year":"2002","unstructured":"Gladman DD, Iba\u00f1ez D, Urowitz MB. Systemic lupus erythematosus disease activity index 2000. J Rheumatol. 2002;29:288\u201391.","journal-title":"J Rheumatol"},{"key":"1790_CR44","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1084\/jem.185.9.1595","volume":"185","author":"R Godiska","year":"1997","unstructured":"Godiska R, Chantry D, Raport CJ, Sozzani S, Allavena P, Leviten D, Mantovani A, Gray PW. Human macrophage-derived chemokine (MDC), a novel chemoattractant for monocytes, monocyte-derived dendritic cells, and natural killer cells. J Exp Med. 1997;185:1595\u2013604.","journal-title":"J Exp Med"},{"key":"1790_CR45","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1074\/jbc.273.3.1764","volume":"273","author":"T Imai","year":"1998","unstructured":"Imai T, Chantry D, Raport CJ, Wood CL, Nishimura M, Godiska R, Yoshie O, Gray PW. Macrophage-derived chemokine is a functional ligand for the CC chemokine receptor 4. J Biol Chem. 1998;273:1764\u20138.","journal-title":"J Biol Chem"},{"key":"1790_CR46","doi-asserted-by":"publisher","DOI":"10.3390\/ijms18112306","author":"S Scheu","year":"2017","unstructured":"Scheu S, Ali S, Ruland C, Arolt V, Alferink J. The C-C chemokines CCL17 and CCL22 and their receptor CCR4 in CNS autoimmunity. Int J Mol Sci. 2017. https:\/\/doi.org\/10.3390\/ijms18112306.","journal-title":"Int J Mol Sci"},{"key":"1790_CR47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/978-3-030-36667-4_8","volume":"1231","author":"N R\u00f6hrle","year":"2020","unstructured":"R\u00f6hrle N, Knott MML, Anz D. CCL22 signaling in the tumor environment. Adv Exp Med Biol. 2020;1231:79\u201396.","journal-title":"Adv Exp Med Biol"},{"key":"1790_CR48","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1172\/JCI12655","volume":"107","author":"P Panina-Bordignon","year":"2001","unstructured":"Panina-Bordignon P, Papi A, Mariani M, Di Lucia P, Casoni G, Bellettato C, Buonsanti C, Miotto D, Mapp C, Villa A, Arrigoni G, Fabbri LM, Sinigaglia F. The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics. J Clin Invest. 2001;107:1357\u201364.","journal-title":"J Clin Invest"},{"key":"1790_CR49","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cyto.2009.10.005","volume":"49","author":"HA Flytlie","year":"2010","unstructured":"Flytlie HA, Hvid M, Lindgreen E, Kofod-Olsen E, Petersen EL, J\u00f8rgensen A, Deleuran M, Vestergaard C, Deleuran B. Expression of MDC\/CCL22 and its receptor CCR4 in rheumatoid arthritis, psoriatic arthritis and osteoarthritis. Cytokine. 2010;49:24\u20139.","journal-title":"Cytokine"},{"key":"1790_CR50","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0165-5728(02)00170-4","volume":"130","author":"S Columba-Cabezas","year":"2002","unstructured":"Columba-Cabezas S, Serafini B, Ambrosini E, Sanchez M, Penna G, Adorini L, Aloisi F. Induction of macrophage-derived chemokine\/CCL22 expression in experimental autoimmune encephalomyelitis and cultured microglia: implications for disease regulation. J Neuroimmunol. 2002;130:10\u201321.","journal-title":"J Neuroimmunol"},{"key":"1790_CR51","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s10875-009-9325-5","volume":"30","author":"CK Wong","year":"2010","unstructured":"Wong CK, Wong PT, Tam LS, Li EK, Chen DP, Lam CW. Elevated production of B cell chemokine CXCL13 is correlated with systemic lupus erythematosus disease activity. J Clin Immunol. 2010;30:45\u201352.","journal-title":"J Clin Immunol"},{"key":"1790_CR52","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1006\/cyto.2000.0757","volume":"12","author":"S Narumi","year":"2000","unstructured":"Narumi S, Takeuchi T, Kobayashi Y, Konishi K. Serum levels of IFN-inducible PROTEIN-10 relating to the activity of systemic lupus erythematosus. Cytokine. 2000;12:1561\u20135.","journal-title":"Cytokine"},{"key":"1790_CR53","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.3899\/jrheum.151129","volume":"43","author":"YB Joo","year":"2016","unstructured":"Joo YB, Park SY, Won S, Bae SC. Differences in clinical features and mortality between childhood-onset and adult-onset systemic lupus erythematosus: a prospective single-center study. J Rheumatol. 2016;43:1490\u20137.","journal-title":"J Rheumatol"},{"key":"1790_CR54","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/art.40697","volume":"71","author":"N Groot","year":"2019","unstructured":"Groot N, Shaikhani D, Teng YKO, de Leeuw K, Bijl M, Dolhain R, Zirkzee E, Fritsch-Stork R, Bultink IEM, Kamphuis S. Long-term clinical outcomes in a cohort of adults with childhood-onset systemic lupus erythematosus. Arthritis Rheumatol (Hoboken, NJ). 2019;71:290\u2013301.","journal-title":"Arthritis Rheumatol (Hoboken, NJ)"},{"key":"1790_CR55","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11926-004-0021-4","volume":"6","author":"LE Schanberg","year":"2004","unstructured":"Schanberg LE, Sandborg C. Dyslipoproteinemia and premature atherosclerosis in pediatric systemic lupus erythematosus. Curr Rheumatol Rep. 2004;6:425\u201333.","journal-title":"Curr Rheumatol Rep"},{"key":"1790_CR56","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1177\/0961203310373937","volume":"19","author":"SP Ardoin","year":"2010","unstructured":"Ardoin SP, Schanberg LE, Sandborg C, Yow E, Barnhart HX, Mieszkalski K, Ilowite NT, von Scheven E, Eberhard A, Levy DM, Kimura Y, Silverman E, Bowyer SL, Punaro L, Singer NG, Sherry DD, McCurdy D, Klein-Gitelman M, Wallace C, Silver R, Wagner-Weiner L, Higgins GC, Brunner HI, Jung LK, Imundo L, Soep JB, Reed AM. Laboratory markers of cardiovascular risk in pediatric SLE: the APPLE baseline cohort. Lupus. 2010;19:1315\u201325.","journal-title":"Lupus"},{"key":"1790_CR57","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1055\/s-0037-1606190","volume":"44","author":"JE Molhoek","year":"2018","unstructured":"Molhoek JE, de Groot PG, Urbanus RT. The Lupus Anticoagulant Paradox. Semin Thromb Hemost. 2018;44:445\u201352.","journal-title":"Semin Thromb Hemost"},{"key":"1790_CR58","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.semarthrit.2015.05.008","volume":"45","author":"JA Avi\u00f1a-Zubieta","year":"2015","unstructured":"Avi\u00f1a-Zubieta JA, Vostretsova K, De Vera MA, Sayre EC, Choi HK. The risk of pulmonary embolism and deep venous thrombosis in systemic lupus erythematosus: a general population-based study. Semin Arthritis Rheum. 2015;45:195\u2013201.","journal-title":"Semin Arthritis Rheum"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01790-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01790-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01790-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T06:51:22Z","timestamp":1764917482000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01790-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,8]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1790"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01790-0","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,8]]},"assertion":[{"value":"29 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"The human samples used in this study were collected from residual routine clinical specimens with broad informed consent from patients, and no ethical approval was required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All the authors approved the final version of the manuscript. All the authors have accepted responsibility for the entire content of this submitted manuscript and approved its submission.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"235"}}